Atelerix Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $737K
Latest Deal Amount
  • Investors
  • 7

Atelerix General Information

Description

Developer of a cell preservation technology designed to store and transport cells and tissues at room temperature. The company's technology uses alginate hydrogels to encapsulate biological products, protecting them from biochemical and physical damage during storage and shipment, enabling doctors and surgeons to overcome the barriers and limitations presented by the current need for cryo-shipping.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • Babraham Hall
  • Cambridge CB22 3AT
  • England, United Kingdom

Atelerix Timeline

2018201920202021
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Atelerix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC 14-May-2020 $737K 00.000 00.000 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2020 00.000 00.000 Completed Generating Revenue
5. Grant 27-Aug-2019 00000 00.000 Completed Startup
4. Early Stage VC 09-May-2019 00000 00.000 00.000 Completed Startup
3. Accelerator/Incubator 01-Jan-2019 000 00.000 Completed Startup
2. Seed Round 02-May-2018 $598K $1.17M 00.000 Completed Startup
1. Accelerator/Incubator 01-Jan-2018 $571K $571K Completed Startup
To view Atelerix’s complete valuation and funding history, request access »

Atelerix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 39,672 $0.000012 $0.81 $0.81 1x $0.81 1.77%
Ordinary 489,254 $0.000012 $1.02 $1.02 1x $1.02 21.81%
To view Atelerix’s complete cap table history, request access »

Atelerix Executive Team (6)

Name Title Board Seat Contact Info
Michael McLean Ph.D Co-Founder, Co-Chief Executive Officer & Board Member
Edwin Wagena Ph.D Co-Chief Executive Officer
Stephen Swioklo Co-Founder & Chief Scientific Officer
Che Connon Co-Founder, Chief Scientific Officer & Board Member
Sanj Kumar Chief Business Officer
You’re viewing 5 of 6 executive team members. Get the full list »

Atelerix Board Members (6)

Name Representing Role Since
Andrew Muir Ph.D UK Innovation & Science Seed Fund Board Member 000 0000
Che Connon Atelerix Co-Founder, Chief Scientific Officer & Board Member 000 0000
Clive Stanway Ph.D Self Board Member 000 0000
Michael McLean Ph.D Atelerix Co-Founder, Co-Chief Executive Officer & Board Member 000 0000
Rita Dhut Newable Board Observer 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Atelerix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atelerix Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovate UK Government 000 0000 000000 0
Newable Corporation Minority 000 0000 000000 0
London Business Angels Angel Group Minority 000 0000 000000 0
Midven Venture Capital Minority 000 0000 000000 0
Oxford Technology Management Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »